Compare AMBO & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBO | HKPD |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | 27 |
| Industry | Other Consumer Services | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 6.9M |
| IPO Year | 2010 | N/A |
| Metric | AMBO | HKPD |
|---|---|---|
| Price | $2.38 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 51.4K | ★ 397.2K |
| Earning Date | 08-05-2025 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 337.04 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $9,469,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $290.54 | ★ N/A |
| Revenue Growth | ★ 0.82 | N/A |
| 52 Week Low | $1.47 | $0.32 |
| 52 Week High | $6.75 | $2.58 |
| Indicator | AMBO | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 37.41 |
| Support Level | $1.91 | $0.34 |
| Resistance Level | $2.56 | $0.71 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 12.12 | 33.30 |
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.